Tokyo Tape
Sign in
← Hyuga Primary Care

Annual report

7133.TEDINET S100R4MH
Period2022-04-01 → 2023-03-31
Filed2023-06-29
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 81
MetricValuePeriodScopeSource row
Revenue¥6.7bn2022-04-01 → 2023-03-31StandaloneNet sales
Revenue¥5.8bn2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥5.1bn2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Revenue¥4.3bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Revenue¥3.4bn2018-04-01 → 2019-03-31dStandaloneNet sales (5-year summary)
Operating income¥530m2022-04-01 → 2023-03-31StandaloneOperating income
Operating income¥519m2021-04-01 → 2022-03-31StandaloneOperating income
Ordinary income¥558m2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income¥506m2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income¥251m2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥122m2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥64m2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥534m2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Profit before tax¥487m2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Net income¥383m2022-04-01 → 2023-03-31StandaloneProfit loss
Net income¥328m2021-04-01 → 2022-03-31StandaloneProfit loss
Net income¥97m2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income¥33m2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income¥14m2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Total assets¥2.9bnat 2023-03-31StandaloneAssets
Total assets¥2.5bnat 2022-03-31StandaloneAssets
Total assets¥2.0bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥1.8bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥1.7bnat 2019-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥1.4bnat 2023-03-31StandaloneLiabilities
Total liabilities¥1.5bnat 2022-03-31StandaloneLiabilities
Net assets / equity¥1.5bnat 2023-03-31StandaloneNet assets
Net assets / equity¥1.1bnat 2022-03-31StandaloneNet assets
Net assets / equity¥609mat 2021-03-31dStandaloneNet assets
Net assets / equity¥503mat 2020-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥470mat 2019-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥568mat 2023-03-31StandaloneCash and deposits
Cash and deposits¥720mat 2022-03-31StandaloneCash and deposits
Cash & equivalents¥568mat 2023-03-31StandaloneCash and cash equivalents
Cash & equivalents¥720mat 2022-03-31StandaloneCash and cash equivalents
Cash & equivalents¥538mat 2021-03-31dStandaloneCash and cash equivalents
Cash & equivalents¥227mat 2020-03-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥342m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥485m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥352m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥35m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥383m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥320m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥78m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥165m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥111m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥17m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥37m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥6m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥53.922022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥47.92021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥28.992020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥9.92019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥1,282.042018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥50.822022-04-01 → 2023-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥43.322021-04-01 → 2022-03-31StandaloneDiluted earnings per share (5-year summary)
Net assets per share¥207.61at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥153.22at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥178.69at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥151.36at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥42,435.9at 2019-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio50.9%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio42.4%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio30.2%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio28.4%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio28.3%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE30.0%2022-04-01 → 2023-03-31StandaloneRate of return on equity (5-year summary)
ROE39.1%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
ROE17.5%2020-04-01 → 2021-03-31dStandaloneRate of return on equity (5-year summary)
ROE6.8%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
ROE3.1%2018-04-01 → 2019-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued3,572,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued3,499,100at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued11,369at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued11,074at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued11,074at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees442at 2023-03-31StandaloneNumber of employees
Employees329at 2022-03-31StandaloneNumber of employees
Employees312at 2021-03-31dStandaloneNumber of employees
Employees283at 2020-03-31dStandaloneNumber of employees
Employees226at 2019-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 94
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentscapex2022-04-01 → 2023-03-31¥83m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsdepreciation2022-04-01 → 2023-03-31¥5m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2023-03-3135 pure
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2023-03-31¥31m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2023-03-31¥31m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment assetsat 2023-03-31¥210m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2023-03-31−¥105m
Reconciling Itemsreconcilingcapex2022-04-01 → 2023-03-31¥12m
Reconciling Itemsreconcilingdepreciation2022-04-01 → 2023-03-31¥9m
Reconciling Itemsreconcilingsegment assetsat 2023-03-31¥710m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2023-03-31−¥388m
Care Planning Servicereportable segmentdepreciation2022-04-01 → 2023-03-31¥25,000
Care Planning Servicereportable segmentemployeesat 2023-03-3121 pure
Care Planning Servicereportable segmentrevenue2022-04-01 → 2023-03-31¥132m
Care Planning Servicereportable segmentrevenue external2022-04-01 → 2023-03-31¥132m
Care Planning Servicereportable segmentsegment assetsat 2023-03-31¥32m
Care Planning Servicereportable segmentsegment profit2022-04-01 → 2023-03-31−¥9m
Home Visit Pharmacist Servicereportable segmentcapex2022-04-01 → 2023-03-31¥115m
Home Visit Pharmacist Servicereportable segmentdepreciation2022-04-01 → 2023-03-31¥61m
Home Visit Pharmacist Servicereportable segmentemployeesat 2023-03-31309 pure
Home Visit Pharmacist Servicereportable segmentrevenue2022-04-01 → 2023-03-31¥5.8bn
Home Visit Pharmacist Servicereportable segmentrevenue external2022-04-01 → 2023-03-31¥5.8bn
Home Visit Pharmacist Servicereportable segmentsegment assetsat 2023-03-31¥1.8bn
Home Visit Pharmacist Servicereportable segmentsegment profit2022-04-01 → 2023-03-31¥666m
Hospital Discharge Support Servicereportable segmentdepreciation2022-04-01 → 2023-03-31¥2m
Hospital Discharge Support Servicereportable segmentemployeesat 2023-03-3113 pure
Hospital Discharge Support Servicereportable segmentrevenue2022-04-01 → 2023-03-31¥40m
Hospital Discharge Support Servicereportable segmentrevenue external2022-04-01 → 2023-03-31¥40m
Hospital Discharge Support Servicereportable segmentsegment assetsat 2023-03-31¥14m
Hospital Discharge Support Servicereportable segmentsegment profit2022-04-01 → 2023-03-31−¥23m
Kirari Primereportable segmentcapex2022-04-01 → 2023-03-31¥5m
Kirari Primereportable segmentdepreciation2022-04-01 → 2023-03-31¥3m
Kirari Primereportable segmentemployeesat 2023-03-3121 pure
Kirari Primereportable segmentrevenue2022-04-01 → 2023-03-31¥634m
Kirari Primereportable segmentrevenue external2022-04-01 → 2023-03-31¥634m
Kirari Primereportable segmentsegment assetsat 2023-03-31¥117m
Kirari Primereportable segmentsegment profit2022-04-01 → 2023-03-31¥390m
—segment totalcapex2022-04-01 → 2023-03-31¥120m
—segment totaldepreciation2022-04-01 → 2023-03-31¥66m
—segment totalrevenue2022-04-01 → 2023-03-31¥6.6bn
—segment totalrevenue external2022-04-01 → 2023-03-31¥6.6bn
—segment totalsegment assetsat 2023-03-31¥2.0bn
—segment totalsegment profit2022-04-01 → 2023-03-31¥1.0bn
Total Of Reportable Segments And Otherssegment totalcapex2022-04-01 → 2023-03-31¥203m
Total Of Reportable Segments And Otherssegment totaldepreciation2022-04-01 → 2023-03-31¥71m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2023-03-31¥6.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2023-03-31¥6.7bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2023-03-31¥2.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2023-03-31¥919m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentscapex2021-04-01 → 2022-03-31¥4m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsdepreciation2021-04-01 → 2022-03-31¥1m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2022-03-31¥14m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2022-03-31¥14m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment assetsat 2022-03-31¥16m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2022-03-31−¥15m
Reconciling Itemsreconcilingcapex2021-04-01 → 2022-03-31¥25m
Reconciling Itemsreconcilingdepreciation2021-04-01 → 2022-03-31¥13m
Reconciling Itemsreconcilingsegment assetsat 2022-03-31¥828m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2022-03-31−¥315m
Care Planning Servicereportable segmentcapex2021-04-01 → 2022-03-31¥110,000
Care Planning Servicereportable segmentdepreciation2021-04-01 → 2022-03-31¥84,000
Care Planning Servicereportable segmentrevenue2021-04-01 → 2022-03-31¥123m
Care Planning Servicereportable segmentrevenue external2021-04-01 → 2022-03-31¥123m
Care Planning Servicereportable segmentsegment assetsat 2022-03-31¥22m
Care Planning Servicereportable segmentsegment profit2021-04-01 → 2022-03-31−¥7m
Home Visit Pharmacist Servicereportable segmentcapex2021-04-01 → 2022-03-31¥128m
Home Visit Pharmacist Servicereportable segmentdepreciation2021-04-01 → 2022-03-31¥51m
Home Visit Pharmacist Servicereportable segmentrevenue2021-04-01 → 2022-03-31¥5.1bn
Home Visit Pharmacist Servicereportable segmentrevenue external2021-04-01 → 2022-03-31¥5.1bn
Home Visit Pharmacist Servicereportable segmentsegment assetsat 2022-03-31¥1.6bn
Home Visit Pharmacist Servicereportable segmentsegment profit2021-04-01 → 2022-03-31¥579m
Hospital Discharge Support Servicereportable segmentdepreciation2021-04-01 → 2022-03-31¥2m
Hospital Discharge Support Servicereportable segmentrevenue2021-04-01 → 2022-03-31¥66m
Hospital Discharge Support Servicereportable segmentrevenue external2021-04-01 → 2022-03-31¥66m
Hospital Discharge Support Servicereportable segmentsegment assetsat 2022-03-31¥16m
Hospital Discharge Support Servicereportable segmentsegment profit2021-04-01 → 2022-03-31¥18m
Kirari Primereportable segmentcapex2021-04-01 → 2022-03-31¥8m
Kirari Primereportable segmentdepreciation2021-04-01 → 2022-03-31¥784,000
Kirari Primereportable segmentrevenue2021-04-01 → 2022-03-31¥433m
Kirari Primereportable segmentrevenue external2021-04-01 → 2022-03-31¥433m
Kirari Primereportable segmentsegment assetsat 2022-03-31¥93m
Kirari Primereportable segmentsegment profit2021-04-01 → 2022-03-31¥259m
—segment totalcapex2021-04-01 → 2022-03-31¥136m
—segment totaldepreciation2021-04-01 → 2022-03-31¥54m
—segment totalrevenue2021-04-01 → 2022-03-31¥5.8bn
—segment totalrevenue external2021-04-01 → 2022-03-31¥5.8bn
—segment totalsegment assetsat 2022-03-31¥1.7bn
—segment totalsegment profit2021-04-01 → 2022-03-31¥848m
Total Of Reportable Segments And Otherssegment totalcapex2021-04-01 → 2022-03-31¥140m
Total Of Reportable Segments And Otherssegment totaldepreciation2021-04-01 → 2022-03-31¥55m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2022-03-31¥5.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2022-03-31¥5.8bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2022-03-31¥1.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2022-03-31¥834m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 987
ItemContextValueUnit
Net salesPrior1YearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember14213000JPY
Net salesPrior1YearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember5782604000JPY
Net salesPrior1YearDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Net salesPrior1YearDuration_NonConsolidatedMember5782604000JPY
Operating incomePrior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000HomeVisitPharmacistServiceReportableSegmentsMember578557000JPY
Operating incomePrior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000KirariPrimeReportableSegmentsMember259077000JPY
Operating incomePrior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000CarePlanningServiceReportableSegmentsMember-7052000JPY
Operating incomePrior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000HospitalDischargeSupportServiceReportableSegmentsMember17755000JPY
Operating incomePrior1YearDuration_NonConsolidatedMember_ReportableSegmentsMember848337000JPY
Operating incomePrior1YearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-14544000JPY
Operating incomePrior1YearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember833792000JPY
Operating incomePrior1YearDuration_NonConsolidatedMember_ReconcilingItemsMember-314685000JPY
Operating incomePrior1YearDuration_NonConsolidatedMember519107000JPY
AssetsPrior1YearInstant_NonConsolidatedMember_jpcrp030000-asr_E37198-000HomeVisitPharmacistServiceReportableSegmentsMember1555397000JPY
AssetsPrior1YearInstant_NonConsolidatedMember_jpcrp030000-asr_E37198-000KirariPrimeReportableSegmentsMember93096000JPY
AssetsPrior1YearInstant_NonConsolidatedMember_jpcrp030000-asr_E37198-000CarePlanningServiceReportableSegmentsMember22486000JPY
AssetsPrior1YearInstant_NonConsolidatedMember_jpcrp030000-asr_E37198-000HospitalDischargeSupportServiceReportableSegmentsMember16383000JPY
AssetsPrior1YearInstant_NonConsolidatedMember_ReportableSegmentsMember1687364000JPY
AssetsPrior1YearInstant_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember16133000JPY
AssetsPrior1YearInstant_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember1703498000JPY
AssetsPrior1YearInstant_NonConsolidatedMember_ReconcilingItemsMember828106000JPY
AssetsPrior1YearInstant_NonConsolidatedMember2531605000JPY
Depreciation segment informationPrior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000HomeVisitPharmacistServiceReportableSegmentsMember50850000JPY
Depreciation segment informationPrior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000KirariPrimeReportableSegmentsMember784000JPY
Depreciation segment informationPrior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000CarePlanningServiceReportableSegmentsMember84000JPY
Depreciation segment informationPrior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000HospitalDischargeSupportServiceReportableSegmentsMember2209000JPY
Depreciation segment informationPrior1YearDuration_NonConsolidatedMember_ReportableSegmentsMember53928000JPY
Depreciation segment informationPrior1YearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1251000JPY
Depreciation segment informationPrior1YearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember55180000JPY
Depreciation segment informationPrior1YearDuration_NonConsolidatedMember_ReconcilingItemsMember13088000JPY
Depreciation segment informationPrior1YearDuration_NonConsolidatedMember68268000JPY
Amortization of goodwill sgaPrior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000HomeVisitPharmacistServiceReportableSegmentsMember10591000JPY
Amortization of goodwill sgaPrior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000KirariPrimeReportableSegmentsMember－JPY
Amortization of goodwill sgaPrior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000CarePlanningServiceReportableSegmentsMember－JPY
Amortization of goodwill sgaPrior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000HospitalDischargeSupportServiceReportableSegmentsMember－JPY
Amortization of goodwill sgaPrior1YearDuration_NonConsolidatedMember_ReportableSegmentsMember10591000JPY
Amortization of goodwill sgaPrior1YearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Amortization of goodwill sgaPrior1YearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember10591000JPY
Amortization of goodwill sgaPrior1YearDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Amortization of goodwill sgaPrior1YearDuration_NonConsolidatedMember10591000JPY
Impairment loss elPrior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000HomeVisitPharmacistServiceReportableSegmentsMember17384000JPY
Impairment loss elPrior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000KirariPrimeReportableSegmentsMember－JPY
Impairment loss elPrior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000CarePlanningServiceReportableSegmentsMember－JPY
Impairment loss elPrior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000HospitalDischargeSupportServiceReportableSegmentsMember－JPY
Impairment loss elPrior1YearDuration_NonConsolidatedMember_ReportableSegmentsMember17384000JPY
Impairment loss elPrior1YearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Impairment loss elPrior1YearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember17384000JPY
Impairment loss elPrior1YearDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Impairment loss elPrior1YearDuration_NonConsolidatedMember17384000JPY
Increase in property plant and equipment and intangible assetsPrior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000HomeVisitPharmacistServiceReportableSegmentsMember127932000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2022-03-31pass rounding
balance sheet identitynon_consolidated 2023-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · operating cash flownon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass